Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas

Cancer Research

Volumn 63, Issue 2, 2003, Pages 413-416

  Okada, Yoshifumi ^a   Hurwitz, Edward E ^a   Esposito, John M ^a   Brower, Melissa A ^a   Nutt, Catherine L ^a   Louis, David N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; PROTEIN P53;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENE TP53; GENOTYPE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

GENE AMPLIFICATION; GENE DOSAGE; GENES, P53; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MUTATION; PARAFFIN EMBEDDING; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0037439688     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kleihues, P., Burger, P. C., Collins, V. P., Newcomb, E. W., Ohgaki, H., and Cavenee, W. K. Glioblastoma. In: P. Kleihues and W. K. Cavenee (eds.), World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System, pp. 29-39. Lyon, France: IARC Press, 2000.
2. Scherer, H. J. Cerebral astrocytomas and their derivatives. Am. J. Cancer, 40: 159-198, 1940.
3. Burger, P. C., Pearl, D. K., Aldape, K., Yates, A. J., Scheithauer, B. W., Passe, S. M., Jenkins, R. B., and James, C. D. Small cell architecture-a histological equivalent of EGFR amplification in glioblastoma multiforme? J. Neuropathol. Exp. Neurol., 60: 1099-1104, 2001.
4. von Deimling, A., von Ammon, K., Schoenfeld, D., Wiestler, O. D., Seizinger, B. R., and Louis, D. N. Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol., 3: 19-26, 1993.
5. Louis, D. N., and Gusella, J. F. A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet., 11: 412-415, 1995.
6. Bachoo, R. M., Maher, E. A., Ligon, K. L., Sharpless, N. E., Chan, S. S., You, M. J., Tang, Y., DeFrances, J., Stover, E., Weissleder, R., Rowitch, D. H., Louis, D. N., and DePinho, R. A. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell, 1: 269-277, 2002.
7. Watanabe, K., Tachibana, O., Sata, K., Yonekawa, Y., Kleihues, P., and Ohgaki, H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol., 6: 217-223; discussion 223-214, 1996.
8. Rusch, V., Klimstra, D., Linkov, I., and Dmitrovsky, E. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development. Cancer Res., 55: 1365-1372, 1995.
9. Zhao, J., Liang, S. X., Savas, L., and Banner, B. F. An immunostaining panel for diagnosis of malignancy in mucinous tumors of the pancreas. Arch. Pathol. Lab. Med., 125: 765-769, 2001.
10. Humphrey, P. A., Wong, A. J., Vogelstein, B., Friedman, H. S., Wemer, M. H., Bigner, D. D., and Bigner, S. H. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res., 48: 2231-2238, 1988.
11. Rubio, M. P., von Deimling, A., Yandell, D. W., Wiestler, O. D., Gusella, J. F., and Louis, D. N. Accumulation of wild-type p53 protein in human astrocytomas. Cancer Res., 53: 3465-3467, 1993.
12. Okada, Y., Nishikawa, R., Matsutani, M., and Louis, D. N. Hypomethylated X chromosome gain and rare isochromosome 12p in diverse intracranial germ cell tumors. J. Neuropathol. Exp. Neurol., 61: 531-538, 2002.
13. Cui, J., Deubler, D. A., Rohr, L. R., Zhu, X. L., Maxwell, T. M., Changus, J. E., and Brothman, A. R. Chromosome 7 abnormalities in prostate cancer detected by dual-color fluorescence in situ hybridization. Cancer Genet. Cytogenet., 107: 51-60, 1998.
14. Sauter, G., Maeda, T., Waldman, F. M., Davis, R. L., and Feuerstein, B. G. Patterns of epidermal growth factor receptor amplification in malignant gliomas. Am. J. Pathol., 148: 1047-1053, 1996.
15. El-Hizawi, S., Lagowski, J. P., Kulesz-Martin, M., and Albor, A. Induction of gene amplification as a gain-of-function phenotype of mutant p53 proteins. Cancer Res., 62: 3264-3270, 2002.
16. Bolteus, A. J., Berens, M. E., and Pilkington, G. J. Migration and invasion in brain neoplasms. Curr. Neurol. Neurosci. Rep., 1: 225-232, 2001.
17. Lund-Johansen, M., Bjerkvig, R., Humphrey, P. A., Bigner, S. H., Bigner, D. D., and Laerum, O. D. Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res., 50: 6039-6044, 1990.
18. Penar, P. L., Khoshyomn, S., Bhushan, A., and Tritton, T. R. Inhibition of epidermal growth factor receptor-associated tyrosine kinase blocks glioblastoma invasion of the brain. Neurosurgery, 40: 141-151, 1997.
19. Laerum, O. D., Nygaar, S. J., Steine, S., Mork, S. J., Engebraaten, O., Peraud, A., Kleihues, P., and Ohgaki, H. Invasiveness in vitro and biological markers in human primary glioblastomas. J. Neurooncol., 54: 1-8, 2001.
20. Lal, A., Glazer, C. A., Martinson, H. M., Friedman, H. S., Archer, G. E., Sampson, J. H., and Riggins, G. J. Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Res., 62: 3335-3339, 2002.
21. Choe, G., Park, J. K., Jouben-Steele, L., Kremen, T. J., Liau, L. M., Vinters, H. V., Cloughesy, T. F., and Mischel, P. S. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin. Cancer Res., 8: 2894-2901, 2002.
22. Smith, J. S., Tachibana, I., Passe, S. M., Huntley, B. K., Borell, T. J., Iturria, N., O'Fallon, J. R., Schaefer, P. L., Scheithauer, B. W., James, C. D., Buckner, J. C., and Jenkins, R. B. PTEN mutation. EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J. Natl. Cancer Inst. (Bethesda), 93: 1246-1256, 2001.
23. Schmidt, M. C., Antweiler, S., Urban, N., Mueller, W., Kuklik, A., Meyer-Puttlitz, B., Wiestler, O. D., Louis, D. N., Fimmers, R., and von Deimling, A. Impact of genotype and morphology on the prognosis of glioblastoma. J. Neuropathol. Exp. Neurol., 61: 321-328, 2002.